Introduction {#s01}
============

Voltage-gated Ca~v~ Ca^2+^ channels are multi-subunit complexes that regulate a variety of biological activities such as gene expression, muscle contraction, and neurotransmitter release. Ca~v~ channels consist of an α~1~ subunit, which forms the pore, and two auxiliary subunits, β and α~2~δ ([@bib40]). Of the multiple Ca~v~ channels that have been characterized (Ca~v~1.x--Ca~v~3.x), Ca~v~2.1 (P/Q-type) and Ca~v~2.2 (N-type) channels play prominent presynaptic roles in regulating neurotransmitter release ([@bib10]). Ca~v~2.1 Ca^2+^ signals promote exocytosis at most synapses, including CA3-CA1 hippocampal synapses ([@bib45]), the calyx of Held auditory brainstem synapse ([@bib11]; [@bib16]), and the parallel fiber--Purkinje cell synapse in the cerebellum ([@bib30]). Although Ca~v~2.2 plays a secondary role to Ca~v~2.1 at many central synapses, Ca~v~2.2 is the major Ca~v~ channel regulating neurotransmitter release from terminals of spinal nociceptive neurons ([@bib12]) and superior cervical ganglion neurons ([@bib2]). Genetic inactivation of Ca~v~2.2 in mice causes no overt phenotypes except for higher pain thresholds ([@bib12]). In contrast, knockout of Ca~v~2.1 causes ataxia, seizures, and premature death ([@bib17]).

Perhaps to support their distinct physiological roles, Ca~v~2.1 and Ca~v~2.2 channels are differentially modulated by a variety of factors, including the Ca^2+^ ions that pass through the pore. Like other high voltage--activated Ca~v~ channels ([@bib26]), Ca~v~2.1 and Ca~v~2.2 undergo Ca^2+^-dependent inactivation (CDI) mediated by calmodulin (CaM) binding to sites in the intracellular C-terminal domain (CTD) of the α~1~ subunit ([@bib22]; [@bib8]). These include a consensus IQ-like domain for binding CaM (IQ) as well as a CaM-binding domain (CBD; [Fig. 1](#fig1){ref-type="fig"}). During a train of depolarizations, the amplitude of Ca~v~2.1 Ca^2+^ currents increases and then declines because of the onset of CDI. The initial increase is caused by Ca^2+^-dependent facilitation (CDF), which also requires CaM ([@bib22]; [@bib8]) and potentially other Ca^2+^ sensor proteins in neurons ([@bib44]). CDF and CDI of Ca~v~2.1 currents contribute to the facilitation and depression, respectively, of synaptic transmission at the calyx of Held ([@bib7]; [@bib11]; [@bib44]) and other brain synapses (reviewed in [@bib4]).

![**CDF modulatory domains in the CTD of Ca~v~2.1 and sequence alignment with analogous regions of Ca~v~2.2.** Vertical bars (\|), identical residues; colons (:), conservative substitutions; periods (.), nonconservative substitutions. Alignment is with human Ca~v~2.1 and 2.2 sequences (GenBank [NM_023035](NM_023035).2, [NM_001127222](NM_001127222).1, [NM_000718](NM_000718).3, and [CM000671](CM000671).2).](JGP_201711841_Fig1){#fig1}

Despite the physiological importance of CDF of Ca~v~2.1 in short-term synaptic plasticity ([@bib32]), there is little evidence that Ca~v~2.2 channels are similarly regulated. In a heterologous expression system, CDF is not observed for Ca~v~2.2 under conditions that evoke robust CDF of Ca~v~2.1 ([@bib26]). At the calyx of Held of mice lacking Ca~v~2.1, Ca~v~2.2 channels compensate for the loss of Ca~v~2.1, but the resulting Ca^2+^ currents do not facilitate or support short-term plasticity ([@bib16]). Although a form of CDF has been reported for Ca~v~2.2 channels in dorsal root ganglion neurons, the mechanism relies on CaM-dependent protein kinase II and is distinct from CaM-dependent CDF of Ca~v~2.1 channels ([@bib41]).

What prevents Ca~v~2.2 from undergoing CDF is unknown but may involve unique sequence elements in the CTD of the α~1~ subunit based on analyses of Ca~v~2.1 splice variants. Alternative splicing of exons in the proximal or distal CTD of the Ca~v~2.1 α~1~ subunit (exons 37 and 47, respectively; [Fig. 1](#fig1){ref-type="fig"}) gives rise to channels with altered CDF ([@bib5]). Notably, the corresponding exons of Ca~v~2.2 also undergo alternative splicing with effects on Ca~v~2.2 current density, modulation by G-proteins, and synaptic trafficking in neurons ([@bib29]; [@bib1]; [@bib27]). The potential of these alternatively spliced exons to regulate CDF of Ca~v~2.2 has not been investigated.

In this study, we tested whether sequences encoded by exons 37 and 46, as well as other regions of the CTD, underlie the absence of CDF in Ca~v~2.2. We find that although splice variation of exons 37 and 46 was inconsequential, the transfer of the key CDF regulatory sites in Ca~v~2.1 to Ca~v~2.2 unmasked strong CDF in the chimeric channels. However, transfer of any of these sites alone was ineffective. Our results reveal an unexpected variance in the molecular determinants controlling CaM regulation of Ca~v~2.1 and Ca~v~2.2, which may shape the distinct coupling of these channels to vesicle release at the synapse.

Materials and methods {#s02}
=====================

cDNAs and molecular biology {#s03}
---------------------------

The following cDNAs were used: Ca~v~2.1 ([NM_001127221](NM_001127221)), Ca~v~2.2 e37a ([AF055477](AF055477)), Ca~v~2.2 e37b ([NM_147141](NM_147141)), β~2A~ ([NM_053851](NM_053851)), and α~2~δ-1 ([NM_000722](NM_000722).3). The plasmid for β~2a~-CaM was a gift from I. Dick (University of Maryland, Baltimore, MD). Chimeras were constructed using NEBuilder HiFi DNA Assembly Cloning System (New England Biolabs) and Ca~v~2.1 and Ca~v~2.2 e37a as templates. The following constructs were generated by swapping the amino acids indicated in parentheses: Ca~v~2.2-CT~2.1~, Ca~v~2.1-CT~2.2~ (1,681--2,334 of Ca~v~2.2, 1,786--2,261 of Ca~v~2.1); Ca~v~2.2-EF~2.1~, Ca~v~2.1-EF~2.2~ (1,681--1,788 of Ca~v~2.2, 1,786--1,892 of Ca~v~2.1); Ca~v~2.2-pre-IQ-IQ~2.1~, Ca~v~2.1-pre-IQ-IQ~2.2~ (1,789--1,875 of Ca~v~2.2, 1,893--1,985 of Ca~v~2.1); and Ca~v~2.2-CBD~2.1~, Ca~v~2.1-CBD~2.2~ (1,912--1,990 of Ca~v~2.2, 2,009--2,084 of Ca~v~2.1). Additional chimeric channels containing subsets of the EF-hand, pre-IQ, IQ, and CBD were generated using the residues indicated above. For Ca~v~2.2 Δe46, the sequence encoding exons 42--45 of Ca~v~2.2 (1,927--2,162) followed by a stop codon was amplified by PCR and cloned into the corresponding site of Ca~v~2.2 as an XbaI fragment. All chimeras and Ca~v~2.2 Δe46 constructs were cloned into the pcDNA6V5His vector. For generating glutathione S-transferase (GST) fusion proteins, sequences corresponding to theaforementioned Ca~v~2 domains were amplified by PCR and cloned into BamHI and XhoI sites of the pGEX-4T-1 vector.

Cell culture and transfection {#s04}
-----------------------------

Human embryonic kidney 293 cells transformed with the SV40 T-antigen (HEK 293T, CRL-3216, RRID:CVCL_0063; ATCC) were maintained in Dulbecco's modified Eagle's medium with 10% FBS at 37°C in a humidified atmosphere with 5% CO~2~. Cells were grown to 80% confluence and transfected using FuGene 6 (Promega) according to the manufacturer's protocol. Cells were plated in 35-mm dishes and transfected with cDNAs encoding Ca~v~ channel subunits (for Ca~v~2.1 and chimeras with Ca~v~2.2 CTDs: 1.0 µg α~1~, 0.5 µg β~2A~, and 0.5 µg α~2~δ~1~; for Ca~v~2.2 and chimeras with Ca~v~2.1 CTDs: 1.8 µg α~1~, 0.6 µg β~2A~, and 0.6 µg α~2~δ~1~). Cotransfection with cDNA encoding enhanced green fluorescent protein (pEGFP, 50 ng) allowed visualization of transfected cells.

Electrophysiological recordings {#s05}
-------------------------------

Whole-cell patch recordings were performed 24--72 h after transfection with a EPC-8 patch clamp amplifier and PatchMaster software (HEKA Elektronik). External recoding solution contained (mM) 150 Tris, 1 MgCl~2~, and 5 CaCl~2~ or BaCl~2~. Intracellular solution contained (mM) 140 *N*-methyl-[d]{.smallcaps}-glucamine, 10 Hepes, 10 or 0.5 EGTA, 2 MgCl~2~, and 2 Mg-ATP. The pH of both solutions was adjusted to 7.3 using methanesulfonic acid. Electrode resistances were 4--6 MΩ in the bath solution. Series resistance was compensated 60--70%. Leak currents were subtracted using a P/−4 protocol. Data were analyzed using Igor Pro software (WaveMetrics). Averaged data represent mean ± SEM and results from at least three independent transfections.

Pull-down binding assays {#s06}
------------------------

The cDNA encoding full-length rat CaM (rCaM1--148 \[[@bib34]\], provided by M. Shea) was expressed in BL21 DE3 *Escherichia coli* bacteria and purified as described previously ([@bib42]). Purified CaM (1--10 µg) was added to GST or GST-tagged Ca~v~2.1 or Ca~v~2.2 proteins (5 µg) immobilized on glutathione Sepharose beads (GE Healthcare Life Sciences). The reaction was brought to a total volume of 750 µl with binding buffer (20 mM Tris-HCl, pH 7.3, 2 mM CaCl~2~, ± 150 mM NaCl; results were similar with or without the added NaCl and so were combined). Binding reactions were incubated at 4°C, rotating for 1 h. The beads were washed three times with 1 ml ice-cold binding buffer, and bound proteins were eluted, resolved by SDS-PAGE, and transferred to nitrocellulose. To detect the GST-proteins, the nitrocellulose was first stained with Ponceau S. Bound CaM was then detected by Western blot with rabbit polyclonal antibodies against CaM (1:1,000, 301 003, RRID:AB_2620046; Synaptic Systems). Blots were processed with HRP-conjugated secondary antibodies (anti--rabbit IgG, 1:4,000, I5006, RRID: AB_1163659; Sigma-Aldrich) and reagents for enhanced chemiluminescent detection (Thermo Fisher Scientific) before autoradiography.

For quantitative analysis, densitometry was performed using a Canon LIDE 200 scanner and ImageJ (NIH) software. The Western blot signal for CaM was normalized to the signal corresponding to the Ponceau-stained GST fusion proteins. Results from at least three independent experiments were pooled for statistical analysis.

Data presentation and statistical analysis {#s07}
------------------------------------------

Data were incorporated into figures using SigmaPlot (Systat Software) and Adobe Illustrator software. Statistical analysis was performed with SigmaPlot or GraphPad Prism software. The data were first analyzed for normality using the Shapiro--Wilk test. For parametric data, significant differences were determined by Student's *t* test or ANOVA with post hoc Dunnett or Tukey test. For nonparametric data, Kruskal--Wallis and post hoc Dunn's tests were used.

Online supplemental material {#s08}
----------------------------

Effects of varying EGTA concentration in the intracellular recording solution are presented in Fig. S1. Fig. S2 shows that enrichment of local CaM does not produce CDF of Ca~v~2.1-EF-pre-IQ-IQ~2.2~ or Ca~v~2.2 e37a.

Results {#s09}
=======

Effects of alternative splicing on CDF of Ca~v~2.2 {#s10}
--------------------------------------------------

In both Ca~v~2.1 and Ca~v~2.2, exon 37 encodes a portion of an EF-hand-like (EF) domains similar to those found in a variety of Ca^2+^ binding proteins ([@bib18]). Conserved in the proximal CTD of all Ca~v~1 and Ca~v~2 channels, the EF domain has been implicated in the regulation of CDI and Mg^2+^-dependent inhibition of Ca~v~1.2 channels ([@bib36]; [@bib21]; [@bib3]). Alternative splicing of exon 37 gives rise to two Ca~v~2.1 variants with distinct EF domains ([Fig. 1](#fig1){ref-type="fig"}), but only channels containing one of the exons (exon 37a) exhibits strong CDF ([@bib5]). The alternatively spliced exons 37a and 37b in Ca~v~2.2 ([@bib1]) are similar in sequence to the corresponding exons in Ca~v~2.1 ([Fig. 1](#fig1){ref-type="fig"}). Notably, previous analysis of CDF in Ca~v~2.2 used the variant containing exon 37b ([@bib26]); the corresponding exon in long variants of Ca~v~2.1 prevents CDF ([@bib5]). Therefore, CDF may have been missed in the previous study ([@bib26]) if exon 37a is required for CDF of Ca~v~2.2.

We tested this possibility in whole-cell patch clamp recordings of transfected HEK 293T cells. To analyze CDF, we used a classic voltage protocol in which the amplitudes of currents evoked before (P1) and after (P2) a conditioning prepulse are compared ([@bib43]). The extracellular solution contained either Ca^2+^ or Ba^2+^, and the intracellular recording solution contained a high concentration of EGTA (10 mM), which blocks CDI while sparing CDF of Ca~v~2 channels ([@bib23]; [@bib26]). With this protocol, Ca~v~2.1 (containing exon 37a) exhibited the hallmarks of CDF: the ratio of P2 to P1 was greater for Ca^2+^ currents (I~Ca~) than for Ba^2+^ currents (I~Ba~) for most prepulse voltages ([Fig. 2 A](#fig2){ref-type="fig"}). Consistent with a role for Ca^2+^ influx during the prepulse in promoting CDF ([@bib23]), the difference between P2/P1 for I~Ca~ and I~Ba~ was greatest at prepulse voltages evoking the peak inward I~Ca~ (20 mV) and was used as a metric for CDF (F~CDF~). Similar to previous findings ([@bib26]), Ca~v~2.2 e37b did not undergo CDF, in that P2/P1 was similar for I~Ca~ and I~Ba~ across all prepulse voltages ([Fig. 2 B](#fig2){ref-type="fig"}) and F~CDF~ was nominal ([Table 1](#tbl1){ref-type="table"}). The P2/P1 ratio for both I~Ca~ and I~Ba~ increased monotonically with prepulse voltage ([Fig. 2 B](#fig2){ref-type="fig"}), likely because of voltage-dependent removal of basal G-protein inhibition ([@bib25]). F~CDF~ was not significantly different for Ca~v~2.2 containing exons 37a or 37b ([Fig. 2 C](#fig2){ref-type="fig"}; and [Table 1](#tbl1){ref-type="table"}), which argued against this exon being permissive for CDF.

![**The absence of CDF in Ca~v~2.2 is not affected by alternative splicing of exon 37. (A--C)** Left, representative I~Ca~ and I~Ba~ evoked before (P1, gray trace) and after (P2, red trace) a prepulse to 20 mV for Ca~v~2.1 (A) and Ca~v~2.2 variants with exon 37b (B) or exon 37a (C). Current traces were overlaid for comparison. Voltage protocol is shown above. P1 and P2 pulses were 10-ms steps from −80 mV to −5 mV (for I~Ca~) or −10 mV (for I~Ba~) 1 s before and 5 ms after, respectively, a 50-ms prepulse to various voltages. For P2 and P1, tail currents were resolved by repolarization to −60 mV for 2 ms before stepping to −80 mV. Right, the ratio of P2 and P1 tail currents is plotted against prepulse voltages for I~Ca~ and I~Ba~. Numbers of cells for I~Ca~ and I~Ba~ are indicated in [Table 1](#tbl1){ref-type="table"}. Data represent mean ± SEM.](JGP_201711841_Fig2){#fig2}

###### F~CDF~ and P2/P1 for I~Ca~ and I~Ba~ from double-pulse protocol (20-mV prepulse)

  Construct          P2/P1 for I~Ca~    P2/P1 for I~Ba~    P-value, I~Ca~ vs. I~Ba~[^a^](#ttbl1n2){ref-type="table-fn"}   F~CDF~              P-value vs. Ca~v~2.1[^b^](#ttbl1n3){ref-type="table-fn"}   P-value vs. Ca~v~2.2a[^b^](#ttbl1n3){ref-type="table-fn"}
  ------------------ ------------------ ------------------ -------------------------------------------------------------- ------------------- ---------------------------------------------------------- -----------------------------------------------------------
  Ca~v~2.1           1.40 ± 0.07 (5)    1.11 ± 0.02 (7)    0.002                                                          0.28 ± 0.07 (5)                                                                0.032
  Ca~v~2.2 e37b      1.28 ± 0.06 (10)   1.35 ± 0.01 (5)    0.437                                                          −0.07 ± 0.06 (10)   0.015                                                      1.000
  Ca~v~2.2 e37a      1.39 ± 0.06 (8)    1.38 ± 0.04 (6)    0.232                                                          0.01 ± 0.06 (7)     0.032                                                      
  Ca~v~2.2-CT~2.1~   1.65 ± 0.10 (13)   1.32 ± 0.04 (11)   0.009                                                          0.33 ± 0.10 (13)    1.000                                                      0.019
  Ca~v~2.1-CT~2.2~   1.16 ± 0.10 (4)    1.16 ± 0.02 (5)    0.717                                                          0.00 ± 0.10 (4)     0.035                                                      1.000

F~CDF~ and P2/P1 (mean ± SEM) were determined as indicated in the text. Number of cells in parentheses.

Determined by Student's *t* test.

Determined by Kruskal--Wallis test and post-hoc Dunn's test.

To determine whether CDF of the Ca~v~2.2 splice variants might be revealed with more physiological stimuli, we analyzed I~Ca~ and I~Ba~ evoked by trains of depolarizations at 100 Hz. The amplitude of each current was normalized to that of the first pulse (Fractional I) and plotted against pulse number. As shown previously ([@bib23]), I~Ca~ mediated by Ca~v~2.1 undergoes a robust and sustained increase, whereas I~Ba~ undergoes relatively modest voltage-dependent facilitation during the train ([Fig. 3 A](#fig3){ref-type="fig"}). The mean of the last five pulses (F~96--100~) was significantly greater for I~Ca~ than for I~Ba~ (∼25%; [Table 2](#tbl2){ref-type="table"}), indicative of CDF. In contrast, there was no difference in F~96--100~ for I~Ca~ and I~Ba~ mediated by Ca~v~2.2 e37a or e37b ([Fig. 3, B and C](#fig3){ref-type="fig"}; and [Table 2](#tbl2){ref-type="table"}). These results confirm that inclusion of exon 37a is insufficient to confer Ca~v~2.2 channels with an ability to undergo CDF, in contrast to the role of the analogous exon in Ca~v~2.1 ([@bib5]).

![**Repetitive depolarizations cause CDF for Ca~v~2.1 but not Ca~v~2.2. (A--C)** I~Ca~ or I~Ba~ were evoked by 2-ms steps from −80 mV to 0 mV for I~Ca~ or −10 mV for I~Ba~ at 100 Hz in cells transfected with Ca~v~2.1 (A) or Ca~v~2.2 containing exon 37b (B) or exon 37a (C). The amplitude of each current was normalized to the first current of the train and plotted against pulse number. For clarity, every fifth point is plotted. Numbers of cells for I~Ca~ and I~Ba~ are indicated in [Table 2](#tbl2){ref-type="table"}. Data represent mean ± SEM.](JGP_201711841_Fig3){#fig3}

###### F~CDF~ calculated from F~96--100~ for I~Ca~ and I~Ba~ from 100-Hz protocol

  Construct                   F~96-100~ for I~Ca~   F~96-100~ for I~Ba~   P-value, I~Ca~ vs. I~Ba~[^a^](#ttbl2n2){ref-type="table-fn"}   F~CDF~              P-value vs. Ca~v~2.1[^b^](#ttbl2n3){ref-type="table-fn"}   P-value vs. Ca~v~2.2a[^b^](#ttbl2n3){ref-type="table-fn"}
  --------------------------- --------------------- --------------------- -------------------------------------------------------------- ------------------- ---------------------------------------------------------- -----------------------------------------------------------
  Ca~v~2.1                    1.33 ± 0.03 (10)      1.06 ± 0.02 (12)      \<0.001                                                        0.27 ± 0.03 (10)                                                               \<0.001
  Ca~v~2.2 e37b               0.91 ± 0.03 (10)      0.83 ± 0.02 (11)      0.067                                                          0.07 ± 0.03 (10)    \<0.001                                                    0.360
  Ca~v~2.2 e37a               0.89 ± 0.02 (10)      0.88 ± 0.04 (10)      0.970                                                          −0.01 ± 0.02 (10)   \<0.001                                                    
  Ca~v~2.2e37a Δ46 (10 mM)    0.95 ± 0.03 (12)      0.83 ± 0.03 (10)      0.005                                                          0.12 ± 0.03 (12)    0.002                                                      0.028
  Ca~v~2.2e37a Δ46 (0.5 mM)   0.82 ± 0.04 (10)      0.82 ± 0.03 (10)      0.968                                                          0.00 ± 0.04 (10)    \<0.001                                                    1.000
  Ca~v~2.2e37b Δ46 (10 mM)    0.94 ± 0.03 (8)       0.94 ± 0.02 (4)       0.985                                                          0.00 ± 0.03 (8)     \<0.001                                                    1.000
  Ca~v~2.2e37b Δ46 (0.5 mM)   0.86 ± 0.04 (5)       0.88 ± 0.02 (5)       0.646                                                          −0.02 ± 0.04 (5)    \<0.001                                                    0.985

F~CDF~ and F~96-100~ (mean ± SEM) were determined as indicated in the text. Number of cells in parentheses.

Determined by Student's *t* test.

Determined by one-way ANOVA test and post-hoc Dunnett\'s test.

For Ca~v~2.1 channels, the insensitivity of CDF to high intracellular Ca^2+^ buffering arises from its dependence on local Ca^2+^ signals detected by the C-terminal lobe of CaM ([@bib6]). In the context of exon 37b, deletion of exon 47 from Ca~v~2.1 (Ca~v~2.1 e37b Δe47) converts CDF to a reliance on global elevations in Ca^2+^, which are sensed by the N-terminal lobe of CaM and can be blunted by a high intracellular concentration of Ca^2+^ chelator ([@bib5]). Therefore, we tested whether deletion of the analogous exon 46 of Ca~v~2.2 e37b (Ca~v~2.2e37b Δex46) might reveal CDF under conditions of limited Ca^2+^ buffering (0.5 mM EGTA). With this approach, there was no significant difference in I~Ca~ and I~Ba~ evoked by the 100-Hz protocol in cells transfected with Ca~v~2.2e37b Δex46 with either 10 or 0.5 mM EGTA ([Fig. 4, A and B](#fig4){ref-type="fig"}; and [Table 2](#tbl2){ref-type="table"}). With 10 mM EGTA, deletion of exon 46 from Ca~v~2.2e37a led to a small increase in the F~96--100~ for I~Ca~ at the end of the train compared with I~Ba~, but F~CDF~ was nominal and significantly weaker than that for Ca~v~2.1 ([Fig. 4, C and D](#fig4){ref-type="fig"}; and [Table 2](#tbl2){ref-type="table"}). Our strategy of manipulating the Ca^2+^-dependent effects of CaM was effective in that strong inactivation of I~Ca~ caused by CDI with 0.5 mM EGTA was significantly reduced with 10 mM EGTA in the intracellular recording solution (Fig. S1). Collectively, our results show that alternative splicing of exons in the proximal and distal CTD do not account for the lack of CDF of Ca~v~2.2.

![**Deletion of exon 46 does not influence the absence of CDF in Ca~v~2.2. (A--D)** As in [Fig. 3](#fig3){ref-type="fig"} except cells transfected with Ca~v~2.2 e37b (A and B) or Ca~v~2.2 e37a (C and D) without exon 46. The intracellular recording solution contained 10 or 0.5 mM EGTA as indicated. Data represent mean ± SEM.](JGP_201711841_Fig4){#fig4}

Role of CaM-regulatory regions in CDF of Ca~v~2 channels {#s11}
--------------------------------------------------------

Mutations of the IQ-like domain that inhibit CaM binding abolish CDF ([@bib8]; [@bib24]), whereas deletion of the CBD diminishes CDF and CDI ([@bib22], [@bib23], [@bib24]). Although its role in CDF of Ca~v~2.1 is not established, the pre-IQ domain upstream of the IQ domain also interacts with CaM and regulates CDI and CDF of Ca~v~1.2 channels ([@bib37]; [@bib21], [@bib20]). Each of these domains is conserved in Ca~v~2.1 and Ca~v~2.2 ([Fig. 1](#fig1){ref-type="fig"}), but key differences in their amino acid sequences may allow CDF of Ca~v~2.1 but not Ca~v~2.2. If so, then CDF should be conferred to Ca~v~2.2 upon transfer of the corresponding domains from Ca~v~2.1. Consistent with this prediction, chimeric Ca~v~2.2 channels containing the CTD of Ca~v~2.1 (Ca~v~2.2-CT~2.1~; Ca~v~2.2a variant was used for all Ca~v~2.2 chimeras) exhibited robust CDF with the double-pulse protocol, with F~CDF~ not significantly different from that of Ca~v~2.1 channels ([Fig. 5 A](#fig5){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}).

![**The CTDs of Ca~v~2.1 and Ca~v~2.2 distinguish their abilities to undergo CDF. (A--E)** As in [Fig. 2](#fig2){ref-type="fig"} (double-pulse protocol) and [Fig. 3](#fig3){ref-type="fig"} (100-Hz protocol) except cells transfected with Ca~v~2.2 channels with the CTD of Ca~v~2.1 (A--C) or Ca~v~2.1 channels with the CTD of Ca~v~2.2 (D and E). In C, interpulse voltage was −140 mV. Gray line representing strong CDF of Ca~v~2.1 I~Ca~ (from [Fig. 3 A](#fig3){ref-type="fig"}) is overlaid for comparison. Data represent mean ± SEM.](JGP_201711841_Fig5){#fig5}

With the 100-Hz protocol, F~96--100~ for Ca~v~2.2-CT~2.1~ I~Ca~ was not as great as that for Ca~v~2.1 ([Fig. 5 B](#fig5){ref-type="fig"} and [Tables 2](#tbl2){ref-type="table"} and [3](#tbl3){ref-type="table"}) perhaps because of closed-state inactivation, which is prominent for Ca~v~2.2 during repetitive depolarizations and relieved by hyperpolarized interpulse voltages ([@bib33]). Ca~v~2.2 inactivation (I~Ca~ and I~Ba~) was stronger than that for Ca~v~2.1 during 100-Hz trains ([Fig. 3](#fig3){ref-type="fig"}) and could partially occlude facilitation of Ca~v~2.2-CT~2.1~ I~Ca~. Changing the interpulse voltage from −80 to −140 mV increased F~96--100~ for I~Ca~ (1.19 ± 0.03 for −140 mV, *n* = 10, vs. 1.09 ± 0.03 for −80 mV, *n* = 15, P = 0.013 by *t* test) to a similar extent as for I~Ba~ (F~96--100~ = 0.99 ± 0.02 for −140 mV, *n* = 10, vs. 0.89 ± 0.03 for −80 mV, *n* = 15, P = 0.014 by *t* test; [Fig. 5 C](#fig5){ref-type="fig"}), such that F~CDF~ was similar regardless of interpulse voltage (0.21 ± 0.03 for −140 mV, *n* = 10, vs. 0.20 ± 0.03 for −80 mV, *n* = 15, P = 0.926 by *t* test; [Fig. 5 C](#fig5){ref-type="fig"}). Thus, although closed-state inactivation does indeed underlie the smaller F~96--100~ for Ca~v~2.2-CT~2.1~ I~Ca~ compared with Ca~v~2.1 I~Ca~, it does not affect the magnitude of CDF. In fact, F~CDF~ of Ca~v~2.2-CT~2.1~ was not significantly different from that for Ca~v~2.1 ([Table 3](#tbl3){ref-type="table"}). Collectively, our results indicate that molecular determinants within the CTD of Ca~v~2.1 are sufficient to enable Ca~v~2.2-CT~2.1~ to undergo CDF.

###### F~CDF~ calculated from F~96--100~ for I~Ca~ and I~Ba~ from 100-Hz protocol

  Construct                     F~96-100~ for *I~Ca~*   F~96-100~ for *I~Ba~*   P-value, I~Ca~ vs. I~Ba~[^a^](#ttbl3n2){ref-type="table-fn"}   F~CDF~              P-value vs. Ca~v~2.1[^b^](#ttbl3n3){ref-type="table-fn"}   P-value vs. Ca~v~2.2a[^b^](#ttbl3n3){ref-type="table-fn"}
  ----------------------------- ----------------------- ----------------------- -------------------------------------------------------------- ------------------- ---------------------------------------------------------- -----------------------------------------------------------
  Ca~v~2.2-CT~2.1~              1.09 ± 0.03 (15)        0.89 ± 0.03 (15)        \<0.001                                                        0.20 ± 0.03 (15)    1.000                                                      
  Ca~v~2.2-pCT~2.1~             1.07 ± 0.02 (13)        0.93 ± 0.02 (11)        \<0.001                                                        0.14 ± 0.02 (13)    0.370                                                      
  Ca~v~2.2-dCT~2.1~             0.90 ± 0.03 (8)         0.92 ± 0.02 (10)        0.914                                                          0.02 ± 0.03 (8)     \<0.001                                                    
  Ca~v~2.2-EF~2.1~              0.85 ± 0.03 (10)        0.88 ± 0.03 (10)        0.520                                                          −0.03 ± 0.03 (10)   \<0.001                                                    
  Ca~v~2.2-pre-IQ-IQ~2.1~       0.90 ± 0.03 (10)        0.92 ± 0.02 (12)        0.583                                                          −0.02 ± 0.03 (10)   \<0.001                                                    
  Ca~v~2.2-CBD~2.1~             0.99 ± 0.03 (10)        0.93 ± 0.02 (11)        0.149                                                          0.06 ± 0.03 (10)    0.006                                                      
  Ca~v~2.2-pre-IQ-IQ-CBD~2.1~   0.95 ± 0.02 (11)        0.95 ± 0.04 (6)         0.689                                                          0.00 ± 0.02 (11)    \<0.001                                                    
  Ca~v~2.2-EF&CBD~2.1~          0.89 ± 0.03 (12)        0.86 ± 0.02 (10)        0.508                                                          0.03 ± 0.03 (12)    0.001                                                      
  Ca~v~2.2-EF-pre-IQ-IQ~2.1~    1.07 ± 0.03 (18)        0.94 ± 0.03 (13)        0.004                                                          0.13 ± 0.03 (18)    0.851                                                      
  Ca~v~2.1-CT~2.2~              1.08 ± 0.04 (10)        1.08 ± 0.02 (5)         0.966                                                          0.00 ± 0.04 (10)                                                               1.000
  Ca~v~2.1-pCT~2.2~             1.05 ± 0.02 (5)         1.01 ± 0.02 (7)         0.073                                                          0.04 ± 0.02 (5)                                                                1.000
  Ca~v~2.1-dCT~2.2~             1.24 ± 0.03 (4)         1.02 ± 0.02 (3)         0.024                                                          0.22 ± 0.03 (4)                                                                0.054
  Ca~v~2.1-EF~2.2~              1.08 ± 0.03 (4)         1.02 ± 0.02 (6)         0.257                                                          0.06 ± 0.03 (4)                                                                1.000
  Ca~v~2.1-pre-IQ-IQ~2.2~       1.03 ± 0.01 (8)         1.03 ± 0.02 (6)         0.831                                                          0.00 ± 0.02 (8)                                                                1.000
  Ca~v~2.1-CBD~2.2~             1.27 ± 0.02 (8)         1.04 ± 0.04 (10)        \<0.001                                                        0.23 ± 0.02 (8)                                                                0.005
  Ca~v~2.1-EF-pre-IQ-IQ~2.2~    1.05 ± 0.01 (11)        1.06 ± 0.02 (11)        0.645                                                          −0.01 ± 0.00 (11)                                                              1.000

F~CDF~ and F~96-100~ (mean ± SEM) were determined as indicated in the text. Number of cells in parentheses.

Determined by Student's *t* test.

Determined by Kruskal--Wallis test and post-hoc Dunn\'s test.

We next tested the converse prediction that transfer of the Ca~v~2.2 CTD to Ca~v~2.1 should blunt CDF. In contrast to the wild-type Ca~v~2.1, I~Ca~ and I~Ba~ behaved similarly in double-pulse and 100-Hz protocols in cells transfected with the chimeric Ca~v~2.1-CT~2.1~ channels ([Fig. 5, D and E](#fig5){ref-type="fig"}; and [Tables 1](#tbl1){ref-type="table"} and [3](#tbl3){ref-type="table"}). To further refine the molecular determinants in the CTD responsible for "turning off" Ca~v~2.2 CDF, we analyzed additional chimeric channels. For these studies, data are shown only for the 100-Hz protocol because similar results were obtained with double-pulse protocols. If the CDF-regulatory domains of Ca~v~2.1 and Ca~v~2.2 distinguish their abilities to undergo CDF, Ca~v~2.2 channels containing the proximal CTD (Ca~v~2.2-pCT~2.1~) but not the distal CTD (Ca~v~2.2-dCT~2.1~) should exhibit CDF. As expected, Ca~v~2.2-pCT~2.1~ underwent CDF ([Fig. 6 A](#fig6){ref-type="fig"} and [Table 3](#tbl3){ref-type="table"}). In contrast, Ca~v~2.2-dCT~2.1~ was similar to wild-type Ca~v~2.2 in that there was no difference in F~96--100~ for I~Ca~ and I~Ba~ ([Fig. 6 B](#fig6){ref-type="fig"} and [Table 3](#tbl3){ref-type="table"}). Consistent with these findings, transfer of the proximal CTD but not the distal CTD of Ca~v~2.2 to Ca~v~2.1 resulted in chimeric channels that did not undergo CDF ([Fig. 6, C and D](#fig6){ref-type="fig"}; and [Table 3](#tbl3){ref-type="table"}). Therefore, the proximal CTD contains the sequence elements that distinguish the ability of Ca~v~2.1 and Ca~v~2.2 to undergo CDF.

![**The proximal CTD containing CDF-regulatory domains in Ca~v~2.1 is not functionally conserved in Ca~v~2.2. (A--D)** As in [Fig. 5 B](#fig5){ref-type="fig"} except cells transfected with Ca~v~2.2 channels containing proximal (A) or distal (B) CTD or Ca~v~2.1 channels containing proximal (C) or distal (D) CTD of Ca~v~2.2. Data represent mean ± SEM.](JGP_201711841_Fig6){#fig6}

We next determined the relative contributions of the EF, pre-IQ, IQ, and CBDs in disabling CDF in Ca~v~2.2 channels. In these experiments, the pre-IQ and IQ sequences were transferred together because they work in concert to transduce effects of CaM in Ca~v~1.2 ([@bib37]; [@bib21]). None of the Ca~v~2.2 chimeras containing these domains from Ca~v~2.1 exhibited CDF ([Fig. 7, A--C](#fig7){ref-type="fig"}; and [Table 3](#tbl3){ref-type="table"}), indicating that the individual CDF-regulatory sites in Ca~v~2.1 are dysfunctional within the context of the Ca~v~2.2 proximal CTD. At the same time, substitution of the pre-IQ-IQ or EF-hand domain, but not the CBD, of Ca~v~2.2 into Ca~v~2.1 abolished CDF normally observed for the wild-type Ca~v~2.1 ([Fig. 7, D--F](#fig7){ref-type="fig"}; and [Table 3](#tbl3){ref-type="table"}). Collectively, these results suggested that functional differences primarily in the EF-hand and pre-IQ-IQ domain of Ca~v~2.2 prevent CDF. To test this, we analyzed chimeric Ca~v~2.2 channels containing subsets of the CDF-regulatory sites in Ca~v~2.1. Of these, only the Ca~v~2.2 chimera containing the EF-hand and pre-IQ-IQ domain (EF-pre-IQ-IQ) of Ca~v~2.1 exhibited CDF ([Fig. 8, A--C](#fig8){ref-type="fig"}; and [Table 3](#tbl3){ref-type="table"}). Conversely, CDF was abolished in Ca~v~2.1 channels containing the Ca~v~2.2 EF-pre-IQ-IQ domain ([Fig. 8 D](#fig8){ref-type="fig"} and [Table 3](#tbl3){ref-type="table"}).

![**EF-hand and pre-IQ-IQ domains are the minimal determinants in the CTD that disable CDF in Ca~v~2.2. (A--F)** As in [Fig. 5 B](#fig5){ref-type="fig"} except cells transfected with Ca~v~2.2 channels containing EF-hand, pre-IQ-IQ, or CBD of Ca~v~2.1 (A--C) or Ca~v~2.1 channels containing corresponding regions of Ca~v~2.2 (D--F). Data represent mean ± SEM.](JGP_201711841_Fig7){#fig7}

![**Both EF-hand and pre-IQ-IQ domains of Ca~v~2.1 are required to unmask CDF in Ca~v~2.2. (A--D)** As in [Fig. 5 B](#fig5){ref-type="fig"} except cells transfected with Ca~v~2.2 channels containing pre-IQ-IQ and CBD (A), EF-hand and CBD (B), or EF-hand and pre-IQ-IQ (C) of Ca~v~2.1 or Ca~v~2.2 channels containing EF-hand and pre-IQ-IQ of Ca~v~2.1 (D). Data represent mean ± SEM.](JGP_201711841_Fig8){#fig8}

The inability of EF-pre-IQ-IQ to support CDF in Ca~v~2.2 could be caused by weaker interactions with CaM compared with this region in Ca~v~2.1. Indeed, past work suggests that CaM binds with lower affinity to the pre-IQ and IQ regions of Ca~v~2.2 than of Ca~v~2.1 ([@bib35]; [@bib26]). To test whether this is the case in the context of EF-pre-IQ-IQ, we compared binding to GST-tagged Ca~v~2.1 or Ca~v~2.2 fusion proteins in pull-down assays. Consistent with previous results ([@bib26]), CaM binding was significantly stronger to the pre-IQ-IQ of Ca~v~2.1 than to this region of Ca~v~2.2 or the GST control ([Fig. 9, A and B](#fig9){ref-type="fig"}). Remarkably, addition of the EF-hand to the pre-IQ-IQ of Ca~v~2.2 greatly enhanced the interaction with CaM such that there was no significant difference in CaM binding to the EF-pre-IQ-IQ domain of Ca~v~2.2 and Ca~v~2.1 ([Fig. 9, A and B](#fig9){ref-type="fig"}). In contrast, CaM bound equally well to the pre-IQ-IQ and EF-pre-IQ-IQ domains of Ca~v~2.1 ([Fig. 9, A and B](#fig9){ref-type="fig"}). The impact of the EF-hand on CaM binding to the Ca~v~2.2 pre-IQ-IQ was particularly apparent with increasing amounts of CaM added to the binding reactions. For all concentrations of CaM tested, the amount of CaM bound to the Ca~v~2.2 pre-IQ-IQ was only ∼20% of that to the Ca~v~2.1 pre-IQ-IQ ([Fig. 9, C and D](#fig9){ref-type="fig"}) whereas there was no difference in CaM binding to the EF-pre-IQ-IQ of the two channels ([Fig. 9, E and F](#fig9){ref-type="fig"}).

![**CaM differentially interacts with pre-IQ-IQ and EF-pre-IQ-IQ of Ca~v~2.1 and Ca~v~2.2 in pull-down assays. (A and B)** GST or GST-tagged Ca~v~2 proteins were incubated with CaM (2.5 µg), and bound CaM was detected by Western blotting. Ponceau staining indicated the amount of each GST protein in the reactions. In B, the signal intensity corresponding to CaM was normalized to that for the GST-protein. A.U., arbitrary units; n.s., not significant; \*\*, P \< 0.001, one-way ANOVA and post hoc Tukey test. Data are representative of four independent experiments. **(C--F)** As in A and B except that variable amounts of CaM (1--10 µg) were used in the assay. In E and F, data were analyzed by two-way ANOVA. There was a significant difference in results obtained for pre-IQ-IQ (P \< 0.01) but not EF-pre-IQ-IQ (P = 0.75) of Ca~v~2.1 and Ca~v~2.2. Data are representative of three independent experiments. Data represent mean ± SEM.](JGP_201711841_Fig9){#fig9}

The similar CaM binding abilities of the EF-pre-IQ-IQ domain of Ca~v~2.1 and Ca~v~2.2 suggested that the lack of CDF in Ca~v~2.2 channels does not simply result from reduced affinity for CaM. If so, then increasing the concentration of CaM to overcome any such differences in CaM binding affinity between Ca~v~2.1 and Ca~v~2.2 should not uncover CDF. To test this prediction, we used a strategy to enrich the local concentration of CaM near Ca~v~ channels in which CaM is tethered to the auxiliary Ca~v~β~2a~ subunit (β~2a~-CaM; [@bib39]). Using β~2a~ as a control, we analyzed the effects of β~2a~-CaM on the amplitude of I~Ca~ evoked by 100-Hz stimuli in cells cotransfected with Ca~v~2.2 or Ca~v~2.1 chimeras containing the EF-pre-IQ-IQ domain of Ca~v~2.2 (Ca~v~2.1-EF-pre-IQ-IQ~2.2~). Coexpression of β~2a~-CaM (verified by Western blots) had no effect on I~Ca~: CDF was not rescued in Ca~v~2.1-EF-pre-IQ-IQ~2.2~, nor was it uncovered in Ca~v~2.2 (Fig. S2). We conclude that the lack of CDF shown by Ca~v~2.2 channels does not arise from weaker binding of CaM, but likely through an inability of the EF-pre-IQ-IQ domain to convert CaM binding into channel conformations that support CDF.

Discussion {#s12}
==========

In this study, we uncovered new insights into the molecular determinants regulating CDF of Ca~v~2 channels. First, we discounted a role for alternatively spliced C-terminal exons 37 and 46. Inclusion of exon 37a, which is permissive for CDF in Ca~v~2.1 ([@bib5]), did not reveal CDF in Ca~v~2.2 ([Figs. 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}), nor did deletion of exon 46 ([Fig. 4](#fig4){ref-type="fig"}), which influences the Ca^2+^ dependence of Ca~v~2.1 CDF ([@bib5]). Second, we identified the EF-hand and pre-IQ-IQ domains as the critical determinants distinguishing the abilities of Ca~v~2.1 and Ca~v~2.2 to undergo CDF. These domains in the proximal CTD of Ca~v~2.2 functionally diverge from those in Ca~v~2.1 because their transfer to Ca~v~2.1 prevented CDF ([Fig. 6 C](#fig6){ref-type="fig"}). Third, we discovered an unexpected role for the EF-hand domain in strengthening the ability of the pre-IQ-IQ of Ca~v~2.2 to bind CaM. Our results support a model in which CaM binds to the EF-pre-IQ-IQ of Ca~v~2.2 in a way that is functionally uncoupled from CDF.

The importance of the IQ domain for CDF is demonstrated by findings that mutation of the initial isoleucine and glutamine in the Ca~v~2.1 IQ domain diminishes CaM binding and blunts CDF ([@bib8]; [@bib24]). Although the IQ domain is highly conserved in Ca~v~1 and Ca~v~2 channels, sequence alterations between Ca~v~ subtypes could underlie functional differences in channel regulation by CaM. By x-ray crystallography, [@bib19] found subtle differences in how CaM interacts with peptides corresponding to the IQ domain Ca~v~2.2 and Ca~v~2.1. These differences include less contact with the methionine at position −1 and greater interaction with phenylalanine at position 1 relative to the central isoleucine (position 0; [@bib19]). These alterations may account for weaker CaM binding to the IQ and pre-IQ-IQ of Ca~v~2.2 compared with Ca~v~2.1 ([Fig. 9](#fig9){ref-type="fig"}; [@bib8]; [@bib26]). However, they are not sufficient to explain the absence of CDF in Ca~v~2.2 channels because transfer of the Ca~v~2.1 pre-IQ-IQ region alone to Ca~v~2.2 did not reverse the inability of Ca~v~2.2 to undergo CDF ([Fig. 7 B](#fig7){ref-type="fig"}). Moreover, Ca~v~2.3 does not undergo CDF, and yet the crystal structures of CaM bound to the Ca~v~2.1 and Ca~v~2.3 IQ domains are nearly identical ([@bib19]; [@bib31]).

In this context, the crystal structure presented by [@bib20] of CaM in complex with the Ca~v~1.2 pre-IQ-IQ may be informative. The structure indicates a 2:1 stoichiometry with one Ca^2+^/CaM bound to the IQ domain and a second to a lower-affinity site in the pre-IQ region. A key tryptophan residue in the Ca~v~1.2 pre-IQ region was identified as an anchoring site for the C-terminal lobe of CaM, and the mutation of this residue disrupted CDF when the initial isoleucine in the IQ-domain was also mutated so as to disrupt CDI ([@bib20]). This tryptophan is conserved among all Ca~v~1 and Ca~v~2 channels and therefore may serve as an analogous region for binding Ca^2+^/CaM in Ca~v~2 channels. Differences between the pre-IQ region of Ca~v~2.1 and Ca~v~2.2 include residues at positions −3, −4, and −12 from this tryptophan, which are all methionines in Ca~v~2.1. Such differences could prevent the ability of CaM bound to the pre-IQ to produce CDF in Ca~v~2.2, which would explain the absence of CDF in any of the Ca~v~2.1 chimeras containing the Ca~v~2.2 pre-IQ-IQ ([Fig. 5, D and E](#fig5){ref-type="fig"}; [Fig. 6 C](#fig6){ref-type="fig"}; and [Fig. 7 E](#fig7){ref-type="fig"}).

Considering the weak binding of CaM to the pre-IQ-IQ of Ca~v~2.2 ([Fig. 9](#fig9){ref-type="fig"}; [@bib8]; [@bib26]), the equivalence of CaM binding of the EF-pre-IQ-IQ of Ca~v~2.2 and Ca~v~2.1 ([Fig. 9](#fig9){ref-type="fig"}) suggests that the EF-hand domain differentially regulates interactions with CaM in the two channels. This is surprising given the strong sequence conservation in the EF-hand domains of Ca~v~2.1 and Ca~v~2.2 ([Fig. 1](#fig1){ref-type="fig"}). The divergent residues in the Ca~v~2.2 EF-hand may be significant enough to facilitate interaction of CaM with the pre-IQ-IQ in ways that are unnecessary for Ca~v~2.1. The Ca~v~2.2 EF-hand might reposition CaM bound to the pre-IQ-IQ so as to prevent CDF, which could explain the absence of CDF in the Ca~v~2.1 chimera containing the Ca~v~2.2 EF-hand ([Fig. 7 D](#fig7){ref-type="fig"}). Alternatively, interactions of the EF-pre-IQ-IQ with other parts of the channel such as the cytoplasmic loops linking domains I and II ([@bib21]) and III and IV ([@bib46]) may be unfavorable for entry of Ca~v~2.2 into the facilitated state that is normally triggered by Ca^2+^/CaM in Ca~v~2.1.

Although it binds CaM and regulates CDI of Ca~v~2.1 ([@bib22], [@bib23]), the CBD plays a more modulatory role and works with the IQ domain to promote CDF ([@bib24]). This is supported by our findings that Ca~v~2.2 channels containing only the Ca~v~2.1 CBD were unable to undergo CDF ([Fig. 7 C](#fig7){ref-type="fig"}). Only when cotransferred with the Ca~v~2.1 EF-hand and pre-IQ-IQ domain was the Ca~v~2.1 CBD effective in producing CDF in Ca~v~2.2 ([Figs. 5 A](#fig5){ref-type="fig"} and [6 D](#fig6){ref-type="fig"}). The CBD may be functionally redundant in Ca~v~2.1 and Ca~v~2.2, because CDF in Ca~v~2.1 channels containing the Ca~v~2.2 CBD was comparable to that in WT Ca~v~2.1 channels ([Fig. 7 F](#fig7){ref-type="fig"}). Considering that CDF was slightly weaker in Ca~v~2.2-pCT~2.1~ than Ca~v~2.2-CT~2.1~ ([Table 3](#tbl3){ref-type="table"}), it may be that the CBD requires the distal CTD of Ca~v~2.1 to fully promote CDF. An understanding of how the EF-hand, pre-IQ-IQ, and CBD domains coordinately regulate CDF is an important challenge for future studies.

The neurophysiological importance of disabling CDF in Ca~v~2.2 channels is not entirely clear but may relate to the major roles of these channels in the peripheral nervous system ([@bib14]). Localized in the presynaptic terminals of small-diameter nociceptive neurons, Ca~v~2.2 channels mediate the release of neuropeptides into the superficial layers of the spinal dorsal horn in response to painful stimuli ([@bib15]; [@bib28]). Because the amount of neurotransmitter released is proportional to the third or fourth power of the presynaptic Ca^2+^ concentration ([@bib9]; [@bib38]), the inability of Ca~v~2.2 to undergo Ca^2+^/CaM-dependent CDF may have evolved to limit additive effects with other forms of Ca~v~2.2 modulation that could collectively exacerbate transmission of painful stimuli. For example, Ca~v~2.2 channel spinal nociceptive neurons undergo a CaMKII-dependent longer-term CDF that is eliminated with peripheral nerve injury ([@bib41]). In sympathetic neurons, Ca~v~2.2 channels are inhibited by a wide range of hormones and neurotransmitters acting via G protein--coupled receptors ([@bib13]). If present in Ca~v~2.2, CDF would oppose this inhibition, leading to improper neurohumoral control of sympathetic outflow.
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